Drug Profile
Research programme: organophosphorus poisoning antidotes - Countervail Corporation/University of California at San Diego
Latest Information Update: 28 Jul 2018
Price :
$50
*
At a glance
- Originator University of California, San Diego
- Developer Countervail Corporation
- Class Oximes
- Mechanism of Action Acetylcholinesterase modulators; Butyrylcholinesterase modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Poisoning
Most Recent Events
- 28 Jul 2018 No recent reports of development identified for research development in Poisoning in USA